MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.51
0.04 (2.72%)
At close: Aug 15, 2025, 3:59 PM
1.51
-0.01%
Pre-market: Aug 18, 2025, 08:00 AM EDT
MIRA Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Cash & Equivalents | 1.21M | 2.83M | 4.14M | 2.82M | 3.53M | 4.6M | 5.87M | 24.82K | 1.35K | 350.98K | n/a | 2.12M | -3.49K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.98K |
Long-Term Investments | n/a | n/a | n/a | n/a | 93.49K | 69.15K | 50K | 50K | n/a | n/a | n/a | 135K | n/a |
Other Long-Term Assets | 35.44K | 35.44K | 35.44K | 83.17K | n/a | n/a | 2.78M | 3.22M | n/a | -0.00 | n/a | 723.85K | -3.49K |
Receivables | n/a | n/a | n/a | n/a | n/a | 11.86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | 11.86K | n/a | 353.37K | 189.69K | 143.43K | n/a | n/a | n/a |
Total Current Assets | 1.36M | 2.89M | 4.23M | 2.93M | 3.71M | 4.86M | 6.07M | 420.72K | 251.07K | 494.4K | n/a | 2.12M | 3.49K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | 1.27K | 5.06K | 114.36K | 132.33K | 146.51K | 363.67K | n/a | 194.19K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 35.44K | 35.44K | 35.44K | 83.17K | 94.76K | 74.21K | 2.95M | 3.4M | 146.51K | 363.67K | n/a | 1.05M | -3.49K |
Total Assets | 1.4M | 2.92M | 4.27M | 3.02M | 3.81M | 4.93M | 9.02M | 3.83M | 397.58K | 858.07K | n/a | 3.18M | n/a |
Account Payables | 100.67K | 723.35K | 692.83K | 782.14K | 636.26K | 538.56K | 510.69K | 645.14K | 918.62K | 905.55K | n/a | 210.14K | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -210.14K | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 5.06K | n/a | 1.8M | 219.54K | 133.06K | n/a | 243.06K | n/a |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | -5.06K | 268.88K | n/a | 685.46K | n/a | n/a | 0.00 | n/a |
Total Current Liabilities | 106.17K | 723.35K | 692.83K | 796.61K | 652.01K | 558.1K | 868.37K | 2.58M | 2.12M | 1.37M | n/a | 534.26K | n/a |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 34.53K | 51.47K | 68.21K | 84.27K | n/a | 136.23K | n/a |
Total Liabilities | 106.17K | 723.35K | 692.83K | 796.61K | 652.01K | 558.1K | 902.9K | 2.63M | 2.19M | 1.45M | n/a | 670.49K | n/a |
Total Debt | n/a | n/a | n/a | n/a | 1.27K | 5.06K | 108.86K | 1.93M | 360.55K | 491.23K | n/a | 431.76K | n/a |
Common Stock | 1.68K | 1.66K | 1.63K | 1.48K | 1.48K | 1.48K | 1.48K | 6.66K | 6.66K | 6.66K | n/a | 6.54K | n/a |
Retained Earnings | -30.92M | -29.14M | -26.74M | -24.69M | -23M | -21.29M | -15.5M | -11.91M | -10.64M | -9.3M | n/a | -3.72M | n/a |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | -135K | -67.99K |
Shareholders Equity | 1.29M | 2.2M | 3.57M | 2.22M | 3.16M | 4.37M | 8.12M | 1.2M | -1.79M | -596.23K | n/a | 2.51M | -67.99K |
Total Investments | n/a | n/a | n/a | 83.17K | 93.49K | 69.15K | 50K | 50K | n/a | n/a | n/a | 135K | 6.98K |